COVID 19 Resources For HIV Providers

SCAETC is committed to protecting both the providers we train and the communities our partners serve. We are closely monitoring the impact of COVID-19. Because we are housed at UNM Health Sciences—an academic medical center—we are focused on COVID-19 in multifaceted ways.

Our ultimate priority is to, first, keep our staff and providers safe. In doing so, we can provide continued, robust training for providers who work with HIV patients. These are unprecedented times and the nuance of the COVID pandemic intersecting with the HIV epidemic requires a rigorous focus on the best and latest information, coupled with the clearest communication.

As the information and best practices change, we will keep these resources up-to-date for you, for your patients and colleagues, and for the communities of all.

COVID-19 Resources for People Living With and Treating HIV

  • Clinical Consultation. The AETC National Clinicians Consultation (NCCC) center provides tele-consultation and guidance on COVID-related inquiries as they pertain to HIV, HCV, and substance use-related prevention and treatment efforts, including PrEP and PEP care, HIV and HCV testing and management, and substance use disorder evaluation and management during the pandemic.
  • COVID-19 Treatment: up-to-date information and teaching slide decks focused on clinical trials and published data related to potential high-impact treatments of persons with COVID-19 (University of Washington, IDEA Program)
  • More AETC Training and Education Resources
This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS). Under grant number U1OHA33225 (South Central AIDS Education and Training Center). It was awarded to the University of New Mexico. No percentage of this project was financed with non-governmental sources. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.